Skip to main content
Medical information Clinical review pending

Genetic Testing

Chromosomal Microarray CMA 750K High Resolution Test

The Chromosomal Microarray (CMA) 750K High Resolution Test is an advanced genetic test used to detect subtle chromosomal abnormalities associated with developmental delays, intellectual disabilities, and congenital anomalies. It offers a detailed analysis of genetic makeup.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
A blood sample is required for this test. Confirm with the laboratory before booking.
Results
Results are typically available within 15 days. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 36,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chromosomal Microarray CMA 750K High Resolution Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained developmental delays
  • ✓Intellectual disabilities
  • ✓Congenital anomalies
  • ✓Multiple miscarriages
  • ✓Family history of genetic disorders
  • ✓Autism spectrum disorder
  • ✓Growth restriction
02

In plain language

What this test helps you understand

This test helps identify underlying genetic causes for developmental delays, intellectual disabilities, and congenital anomalies. It provides detailed information about chromosomal variations, aiding in diagnosis, prognosis, and guiding management strategies. Results can also inform family planning decisions.
The Chromosomal Microarray (CMA) 750K High Resolution Test is an advanced diagnostic tool used to identify genetic abnormalities that may lead to developmental delays, intellectual disabilities, or congenital anomalies. This test provides a comprehensive analysis of a patient’s genetic makeup, offering insights that are crucial for effective treatment and management. It measures variations in chromosomes, specifically looking for copy number variations (CNVs) and other genetic anomalies that standard karyotyping may miss. This high-resolution analysis is particularly useful in uncovering subtle genetic changes that can have significant clinical implications.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Confirm with the laboratory before booking.
SampleA blood sample is required for this test. Confirm with the laboratory before booking.
MethodologyChromosomal Microarray (CMA) analysis.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects copy number variations (CNVs) and other chromosomal abnormalities but may not detect all types of genetic changes, such as single gene mutations or balanced translocations. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

CMA is a high-resolution genetic test that looks for changes in the number of copies of specific DNA segments across the entire genome. It can detect deletions and duplications that may not be visible with standard chromosome tests.
This test is often recommended for individuals with unexplained developmental delays, intellectual disabilities, autism spectrum disorder, multiple congenital anomalies, or a family history of genetic disorders.
A blood sample is typically required for this test.
Results are generally available within 15 days, but this can vary. Confirm with the laboratory before booking.
No, CMA detects specific types of genetic changes (copy number variations). It may not detect all genetic conditions, such as single gene mutations. Your doctor can advise on the most appropriate testing.
Results should be interpreted by a qualified healthcare professional, often in consultation with a genetic counselor, to understand the implications for your health or your child's health.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp